Insider trade

Dexcom (DXCM): Officer sold ~$202K

Sadie Stern, Officer at Dexcom, sold ~$202K of Dexcom shares.

~$202K
Approx. value · 2,565 sh @ $78.62
121K
Holds after · shares reported
Traded
Oct 27, 2026
Filed
Oct 28, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 27, 2026InsiderOfficer sold ~$227K of DXCM shares in the open market
  2. Sep 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 10, 2026, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom” or the “Company”), pursuant to the Amended and Restated Bylaws of the Company, increased the size of the Board to thirteen directors and appointed Glenn S. Boehnlein as a director, effective immediately.”
  3. Sep 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 10, 2026, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom” or the “Company”) appointed Jereme Sylvain, the Company’s EVP, Chief Financial Officer, to the role of EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026.”
  4. Sep 10, 2026InsiderOfficer sold ~$303K of DXCM shares in the open market
  5. Sep 14, 2026InsiderDirector sold ~$130K of DXCM shares in the open market
  6. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$692K)
  7. Sep 28, 2026InsiderOfficer sold ~$221K of DXCM shares in the open market
  8. Oct 15, 2026InsiderOfficer sold ~$145K of DXCM shares in the open market
  9. Oct 27, 2026 · this disclosureInsiderOfficer sold ~$202K of DXCM shares in the open market

What came next

  1. Oct 29, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  2. Nov 10, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.0%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Dexcom

For Dexcom, OQRO holds 20 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DXCM page.

Other recent filings by Sadie Stern, EVP Chief People & Culture Off

The full history of Sadie Stern, EVP Chief People & Culture Off is on the profile page.

How this filing works

Explore the data

Common questions

Which Dexcom (DXCM) insider traded, and how much?

Sadie Stern, Officer at Dexcom, sold ~$202K of Dexcom shares. 2,565 shares at $78.62.

When did it happen, and when was it made public?

Traded: Oct 27, 2026. Filed: Oct 28, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Dexcom recently?

For Dexcom, OQRO holds 20 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the DXCM page.

Does this mean DXCM stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Dexcom

Everything OQRO holds on this company is on its DXCM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data